We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Independent Bank
INDB
$4.08B
| $296K | 0.01% |
+6,358
| New | +$306K |
|
|
WSTC
1327
DELISTED
West Corporation
WSTC
| $295K | 0.01% |
13,704
-20,665
| -60% | -$496K |
|
|
MTGE
1328
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $295K | 0.01% |
+21,120
| New | +$310K |
|
1329
Encompass Health
EHC
$11.4B
| $294K | 0.01% |
+10,605
| New | +$302K |
|
1330
Vail Resorts
MTN
$5.66B
| $294K | 0.01% |
2,295
-1,878
| -45% | -$221K |
|
1331
AAR Corp
AIR
$5.43B
| $292K | 0.01% |
11,102
-10,193
| -48% | -$238K |
|
1332
Groupon
GRPN
$1.07B
| $291K | 0.01% |
+4,738
| New | +$305K |
|
1333
Methanex
MEOH
$4.08B
| $291K | 0.01% |
+8,802
| New | +$337K |
|
1334
Minerals Technologies
MTX
$2.27B
| $290K | 0.01% |
+6,332
| New | +$355K |
|
1335
PayPal
PYPL
$50.5B
| $290K | 0.01% |
8,013
-1,984
| -20% | -$70K |
|
|
PDCO
1336
DELISTED
Patterson Companies, Inc.
PDCO
| $290K | 0.01% |
+6,404
| New | +$294K |
|
|
SPN
1337
DELISTED
Superior Energy Services, Inc.
SPN
| $290K | 0.01% |
+2,155
| New | +$321K |
|
|
PERY
1338
DELISTED
Perry Ellis International Inc
PERY
| $289K | 0.01% |
+15,688
| New | +$323K |
|
1339
Cisco
CSCO
$454B
| $288K | 0.01% |
10,591
-59,908
| -85% | -$1.65M |
|
1340
CAE Inc. Common Shares
CAE
$8.38B
| $287K | 0.01% |
+25,900
| New | +$290K |
|
1341
Amdocs
DOX
$6.03B
| $287K | 0.01% |
5,262
-27,173
| -84% | -$1.56M |
|
|
RPXC
1342
DELISTED
RPX Corporation
RPXC
| $287K | 0.01% |
+26,103
| New | +$354K |
|
1343
Federal Realty Investment Trust
FRT
$10.8B
| $286K | 0.01% |
+1,957
| New | +$283K |
|
1344
Wendy's
WEN
$1.48B
| $286K | 0.01% |
26,600
-34,805
| -57% | -$343K |
|
|
FLOW
1345
DELISTED
SPX FLOW, Inc.
FLOW
| $285K | 0.01% |
10,200
-8,451
| -45% | -$278K |
|
1346
Clean Harbors
CLH
$17.2B
| $284K | 0.01% |
6,816
+2
| +0% | +$87 |
|
|
HIBB
1347
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $284K | 0.01% |
+9,411
| New | +$311K |
|
1348
Euronet Worldwide
EEFT
$3.16B
| $282K | 0.01% |
3,900
-3,938
| -50% | -$301K |
|
1349
MBIA
MBI
$277M
| $282K | 0.01% |
43,442
+2,248
| +5% | +$15.2K |
|
1350
Neogen
NEOG
$2.01B
| $280K | 0.01% |
13,216
-3,987
| -23% | -$81.3K |
|
Similar funds
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
MWAM
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.